63
Growth Score
pts
Heat Score
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
HaemO2 is a synthetic biology project based at the University of Essex, UK, that is developing a third generation artificial blood.
About the Company
HaemO2 is a synthetic biology project based at the University of Essex, UK, that is developing a third generation artificial blood substitute.
Hemoglobin is the key protein in red blood cells that carries oxygen around our bodies. A haemoglobin-based oxygen carrier (HBOC) could be used as a substitute for blood lost in surgery or trauma, but to
date attempts to make a safe and effective HBOC have proved problematic. The redox activity of heme iron, when outside the safe confines of the red blood cell, is considered a key problem when attempting to engineer a safe (HBOC).
